Identification of the galactose binding domain of the adeno-associated virus serotype 9 capsid
about
Parvovirus glycan interactionsStructural Insights into Adeno-Associated Virus Serotype 5Electron microscopy analysis of a disaccharide analog complex reveals receptor interactions of adeno-associated virusStructure of neurotropic adeno-associated virus AAVrh.8.The 2.8 Å Electron Microscopy Structure of Adeno-Associated Virus-DJ Bound by a Heparinoid Pentasaccharide.Gene transfer to the CNS using recombinant adeno-associated virusAdeno-associated virus: fit to serveMultiple roles for sialylated glycans in determining the cardiopulmonary tropism of adeno-associated virus 4Characterization of naturally-occurring humoral immunity to AAV in sheep.Functional analysis of the putative integrin recognition motif on adeno-associated virus 9.In Silico Reconstruction of the Viral Evolutionary Lineage Yields a Potent Gene Therapy VectorGlycan binding avidity determines the systemic fate of adeno-associated virus type 9.Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene TherapyRecombinant AAV9-TLK1B administration ameliorates fractionated radiation-induced xerostomiaWidespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector.Efficient gene delivery and selective transduction of astrocytes in the mammalian brain using viral vectors.Engraftment of a galactose receptor footprint onto adeno-associated viral capsids improves transduction efficiency.Characterization of interactions between heparin/glycosaminoglycan and adeno-associated virus.Drawing a high-resolution functional map of adeno-associated virus capsid by massively parallel sequencing.Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding SitemiR-29b supplementation decreases expression of matrix proteins and improves alveolarization in mice exposed to maternal inflammation and neonatal hyperoxia.In vivo tissue-tropism of adeno-associated viral vectors.Insight into the mechanisms of enhanced retinal transduction by the engineered AAV2 capsid variant -7m8.Trafficking of adeno-associated virus vectors across a model of the blood-brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells.Adeno-Associated Virus (AAV) as a Vector for Gene Therapy.Intracisternal delivery of AAV9 results in oligodendrocyte and motor neuron transduction in the whole central nervous system of cats.Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion.In Vivo Selection of a Computationally Designed SCHEMA AAV Library Yields a Novel Variant for Infection of Adult Neural Stem Cells in the SVZ.Mapping the Structural Determinants Required for AAVrh.10 Transport across the Blood-Brain Barrier.RTB lectin-mediated delivery of lysosomal α-l-iduronidase mitigates disease manifestations systemically including the central nervous system.Noninvasive gene delivery to foveal cones for vision restoration.A Rationally Engineered Capsid Variant of AAV9 for Systemic CNS-Directed and Peripheral Tissue-Detargeted Gene Delivery in Neonates.The Assembly-Activating Protein Promotes Stability and Interactions between AAV's Viral Proteins to Nucleate Capsid Assembly.
P2860
Q26858992-671769D0-8487-4096-BB19-81F9A5F81DDDQ27679454-FA709EA9-95BA-4275-A99F-4A739F594CA7Q27679952-8E3A8A9F-6F63-449E-B660-042E78975E22Q30152836-067CA7B2-089B-4871-8407-B16DC2D4B024Q33633258-6A756DFB-78E1-449F-8C14-3279F17E5F30Q34055904-D8882936-4579-4624-BCF3-260170467128Q34332817-CE9FC49A-5FB0-4B29-9844-2DB451D027E1Q34997974-BF5E1C30-E726-45C7-8F8E-1325AF12E0F9Q35005408-3FB77F85-53E9-4C80-BC9C-8C9F2EB26BBBQ35121258-1B41DDA9-70E2-4479-ABF9-90D7E9F2EF0AQ35952312-87FD1802-7945-4908-9633-76A02EA57272Q36276561-C03EF02E-E267-4C9F-81DC-6A8048EC490FQ36406869-AC47B51F-03BC-4F84-816B-B16275258ADFQ36945801-6A9756B8-10B6-4970-82D4-83ECA9C30C1CQ36951265-DD84E026-D590-425B-B783-87D3E24C93B4Q36983576-D90C17DA-9330-43EB-A286-E9ED40A9A48FQ37213826-93E3F423-B5F1-43C0-84F2-8B8149FAF967Q37385088-F527F743-7950-494A-885A-446103A5F7EAQ37614775-433495F9-D64A-4AE3-88D1-2BD84C28797EQ38787435-62818A23-8C31-4C70-B6CA-56EF29B3A686Q38803350-166CD6A3-26E4-4C88-ACAA-8BD318E89736Q38824171-5B17DC94-318C-48C9-AEFA-2C471BF552A0Q39130497-C101D28D-1C3B-4F2F-A379-AAF09B4C9986Q39309884-DC91B2B9-3B8B-45C6-A9CD-2D3F22D5FF13Q39409371-AAA7FA0D-15CC-4220-8035-5EE990CB2A10Q39415889-8EE67D9A-E6CE-4ECB-86B9-F33C40EB3437Q40108800-EBD1817D-9FAB-49A8-B7A3-3E1793640D12Q41921977-19BC9B2B-5513-4232-8390-D1FA74A1E2D4Q45875010-B29D99D5-5ACF-45D3-A333-DD2C2B07FC64Q45875364-671F3682-4F39-4FA2-B58E-F7C97FF38ECAQ47549141-9977997E-D854-4B15-BFA0-5351D9AA57B3Q54210504-D90CC52E-C54D-4E50-A6DA-EB5838986F0FQ54217119-4881E39F-0E94-4178-9170-044651A8118E
P2860
Identification of the galactose binding domain of the adeno-associated virus serotype 9 capsid
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Identification of the galactos ...... ciated virus serotype 9 capsid
@ast
Identification of the galactos ...... ciated virus serotype 9 capsid
@en
type
label
Identification of the galactos ...... ciated virus serotype 9 capsid
@ast
Identification of the galactos ...... ciated virus serotype 9 capsid
@en
prefLabel
Identification of the galactos ...... ciated virus serotype 9 capsid
@ast
Identification of the galactos ...... ciated virus serotype 9 capsid
@en
P2860
P50
P356
P1433
P1476
Identification of the galactos ...... ciated virus serotype 9 capsid
@en
P2093
Christie L Bell
Mavis Agbandje-McKenna
P2860
P304
P356
10.1128/JVI.00448-12
P407
P577
2012-04-18T00:00:00Z